Abstract
Polycystic ovary syndrome (PCOS) is an extremely common disorder in women of reproductive age. Affected patients frequently complain of menstrual irregularities, symptoms of hyperandrogenism, and infertility. The entity was first characterized in 1935 by Stein and Leventhal (1), who observed enlarged ovaries, obesity, hirsutism, and infertility associated with chronic anovulation (2). Because PCOS is associated in the long term with diabetes, heart disease, and cancer (1), accurate diagnosis and treatment are extremely important. In recent years, it has become increasingly evident that PCOS is also a significant risk factor for obstructive sleep apnea (OSA). OSA is characterized by sleep-disordered breathing (SDB) and can be a debilitating condition leading to serious health problems if not treated or diagnosed adequately.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Guzick, D.S., Polycystic ovary syndrome. Obstet Gynecol, 2004;103(1):181–193.
Legro, R.S., Diagnostic criteria in polycystic ovary syndrome. Semin Reprod Med, 2003;21(3):267–275.
Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 con-sensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod, 2004;19(1):41–47.
Hatch, R., R.L. Rosenfield, M.H. Kim, and D. Tredway, Hirsutism: implications, etiology, and management. Am J Obstet Gynecol, 1981;140:815–830.
Young, T., J. Skatrud, and P.E. Peppard, Risk factors for obstructive sleep apnea in adults. JAMA, 2004;291(16):2013–2016.
Attarian, H.P. and A.N. Sabri, When to suspect obstructive sleep apnea syndrome. Symptoms may be subtle, but treatment is straightforward. Postgrad Med, 2002;111(3):70–76.
Young, T., P.E. Peppard, and D.J. Gottlieb, Epidemiology of obstructive sleep apnea: a popula-tion health perspective. Am J Respir Crit Care Med, 2002;165(9):1217–1239.
Farney, R.J., A. Lugo, R.L. Jensen, J.M. Walker, and T.V. Cloward, Simultaneous use of antide-pressant and antihypertensive medications increases likelihood of diagnosis of obstructive sleep apnea syndrome. Chest, 2004;125(4):1279–1285.
Vgontzas, A.N., E.O. Bixler, T.L. Tan, D. Kantner, L.F. Martin, and A. Kales, Obesity without sleep apnea is associated with daytime sleepiness. Arch Intern Med, 1998;158(12):1333–1337.
Dixon, J.B., L.M. Schachter, and P.E. O’Brien, Predicting sleep apnea and excessive day sleepi-ness in the severely obese: indicators for polysomnography. Chest, 2003;123(4):1134–1141.
Driscoll, D.A., Polycystic ovary syndrome in adolescence. Semin Reprod Med, 2003;21(3):301–307.
Exar, E.N. and N.A. Collop, The upper airway resistance syndrome. Chest, 1999;115(4):1127–1139.
Seneviratne, U. and K. Puvanendran, Excessive daytime sleepiness in obstructive sleep apnea: prevalence, severity, and predictors. Sleep Med, 2004;5(4):339–343.
Franks, S., Polycystic ovary syndrome. N Engl JMed, 1995;333(13):853–861.
Knochenhauer, E.S., T.J. Key, M. Kahsar-Miller, W. Waggoner, L.R. Boots, and R. Azziz, Preva-lence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab, 1998;83(9):3078–3082.
Wright, C.E., J.V. Zborowski, E.O. Talbott, K. McHugh-Pemu, and A. Youk, Dietary intake, physical activity, and obesity in women with polycystic ovary syndrome. Int J Obes Relat Metab Disord, 2004;28(8):1026–1032.
Winters, S.J., E.O. Talbott, D.D. Guzick, J.V. Zborowski, and K.P. McHugh, Serum testosterone levels decrease in middle age in women with the polycystic ovary syndrome. Fertil Steril, 2000;73(4):724–729.
Young, T., M. Palta, J. Dempsey, J. Skatrud, S. Weber, and S. Badr, The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med, 1993;328(17):1230–1235.
Bixler, E.O., A.N. Vgontzas, H.M. Lin, et al., Prevalence of sleep-disordered breathing in women: effects of gender. Am J Respir Crit Care Med, 2001;163(3 Pt 1):608–613.
Rajala, R., M. Partinene, T. Sane, R. Pelkonen, K. Huikuri, and A.M. Sappalainen, Obstructive sleep apnoea syndrome in morbidly obese patients. J Intern Med, 1991;230(2):125–129.
Peppard, P.E., T. Young, M. Palta, J. Dempsey, and J. Skatrud, Longitudinal study of moderate weight change and sleep-disordered breathing. JAMA, 2000;284(23):3015–3021.
Guilleminault, C., R. Stoohs, Y. Kim, R. Chervin, J. Black, and A. Clerk, Upper airway sleep-disordered breathing in women. Ann Intern Med, 1995;122(7):493–501.
Young, T., L. Finn, D. Austin, and A. Peterson, Menopausal status and sleep-disordered breath-ing in the Wisconsin Sleep Cohort Study. Am J Respir Crit Care Med, 2003;167(9):1181–1185.
Legro, R.S., A.R. Kunselman, W.C. Dodson, and A. Dunaif, Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospec-tive, controlled study in 254 affected women. J Clin Endocrinol Metab, 1999;84(1):165–169.
Legro, R.S., A.R. Kunselman, and A. Dunaif, Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome. Am J Med, 2001;111(8):607–613.
Talbott, E.O., D.S. Guzick, K. Sutton-Tyrrell, et al., Evidence for association between polycystic ovary syndrome and premature carotid atherosclerosis in middle-aged women. Arterioscler Thromb Vasc Biol, 2000;20(11):2414–2421.
Escobar-Morreale, H.F., G. Villuendas, J.I. Botella-Carretero, J. Sancho, J.L. San Millán, Obe-sity, and not insulin resistance, is the major determinant of serum inflammatory cardiovascular risk markers in pre-menopausal women. Diabetologia, 2003;46(5):625–633.
Pierpoint, T., P.M. McKeigue, A.J. Isaacs, S.H. Wild, and H.S. Jacobs, Mortality of women with polycystic ovary syndrome at long-term follow-up. J Clin Epidemiol, 1998;51(7):581–586.
Redline, S. and K.P. Strohl, Recognition and consequences of obstructive sleep apnea hypopnea syndrome. Clin Chest Med, 1998;19(1):1–19.
Elmasry, A., E. Lindberg, C. Berne, et al., Sleep-disordered breathing and glucose metabolism in hypertensive men: a population-based study. J Intern Med, 2001;249(2):153–161.
Coughlin, S.R., L. Mawdsley, J.A. Mugarza, P.M.A. Calverley, and J.P.H. Wilding, Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J, 2004;25(9):735–741.
Resnick, H.E., S. Redline, E. Shahar, et al., Diabetes and sleep disturbances: findings from the Sleep Heart Health Study. Diabetes Care, 2003;26(3):702–709.
Peppard, P.E., T. Young, M. Palta, and J. Skatrud, Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med, 2000;342(19):1378–1384.
Shahar, E., C.W. Whitney, S. Redline, et al., Sleep-disordered breathing and cardiovascular dis-ease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med, 2001;163(1):19–25.
Shamsuzzaman, A.S., B.J. Gersh, and V.K. Somers, Obstructive sleep apnea: implications for cardiac and vascular disease. JAMA, 2003;290(14):1906–1914.
Laaban, J.P., S. Pascal-Sebaoun, E. Bloch, E. Orvoën-Frija, J.M. Oppert, and G. Huchon, Left ventricular systolic dysfunction in patients with obstructive sleep apnea syndrome. Chest, 2002;122(4):1133–1138.
Neau, J.P., J. Paquereau, J.C. Meurice, J.J. Chavagnat, and R. Gil, Stroke and sleep apnoea: cause or consequence? Sleep Med Rev, 2002;6(6):457–469.
Bartlett, D.J., C. Rae, C.H. Thompson, et al., Hippocampal area metabolites relate to severity and cognitive function in obstructive sleep apnea. Sleep Med, 2004;5(6):593–596.
Sassani, A., L.J. Findley, M. Kryger, E. Goldlust, C. George, and T.M. Davidson, Reducing motor-vehicle collisions, costs, and fatalities by treating obstructive sleep apnea syndrome. Sleep, 2004;27(3):453–458.
Goldstein, B.J., Insulin resistance as the core defect in type 2 diabetes mellitus. Am J Cardiol, 2002;90(5A):3G–10G.
Ovalle, F. and R. Azziz, Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mel-litus. Fertil Steril, 2002;77(6): 1095–1105.
Bjorntorp, P., The regulation of adipose tissue distribution in humans. Int J Obes Relat Metab Disord, 1996;20(4):291–302.
Jensen, M.D., J.A. Kanaley, J.E. Reed, and P.F. Sheedy, Measurement of abdominal and visceral fat with computed tomography and dual-energy x-ray absorptiometry. Am J Clin Nutr, 1995;61(2):274–278.
Dunaif, A., K.R. Segal, W. Futterweit, and A. Dobrjawsky, Profound peripheral insulin resis-tance, independent of obesity, in polycystic ovarian syndrome. Diabetes, 1989;38:1165–1174.
Morales, A.J., G.A. Laughlin, T. Bützow, H. Maheshwari, G. Baumann, and S.S.C. Yen, Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syn-drome: common and distinct features. J Clin Endocrinol Metab, 1996;81(8):2854–2864.
Filicori, M., N. Santoro, G.R. Merriam, and W.F.C. Crowley, Characterization of the physiologi-cal pattern of episodic gonadotropin secretion throughout the human menstrual cycle. J Clin Endocrinol Metab, 1986;62(6):1136–1144.
Soules, M.R., R.A. Steiner, N.L. Cohen, W.J. Bremner, and D.K. Clifton, Nocturnal slowing of pulsatile luteinizing hormone secretion in women during the follicular phase of the menstrual cycle. J Clin Endocrinol Metab, 1985;61(1):43–49.
Apter, D., T. Bützow, G.A. Laughlin, and S.S.C. Yen, Accelerated 24-hour luteinizing hormone pulsatile activity in adolescent girls with ovarian hyperandrogenism: relevance to the develop-mental phase of polycystic ovarian syndrome. J Clin Endocrinol Metab, 1994;79(1):119–125.
Taylor, A.E., B. McCourt, K.A. Martin, et al., Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome. J Clin Endocrinol Metab, 1997;82(7):2248–2256.
Waldstreicher, J., N.F. Santoro, J.E. Hall, M. Filicori, and W.F. Crowley, Hyperfunction of the hypothalamic-pituitary axis in women with polycystic ovarian disease: indirect evidence for par-tial gonadotroph desensitization. J Clin Endocrinol Metab, 1988;66(1):165–172.
Zumoff, B., R. Freeman, S. Coupey, P. Saenger, M. Markowitz, and J. Kream, A chronobiologic abnormality in luteinizing hormone secretion in teenage girls with the polycystic-ovary syndrome. NEnglJMed, 1983;309(20):1206–1209.
Jordan, A.S., D.P. White, and R.B. Fogel, Recent advances in understanding the pathogenesis of obstructive sleep apnea. Curr Opin Pulm Med, 2003;9(6):459–464.
Malhotra, A., Y. Huang, R.B. Fogel, et al., The male predisposition to pharyngeal collapse: importance of airway length. Am J Respir Crit Care Med, 2002;166(10):1388–1395.
Millman, R.P., C.C Carlisle, S.T. McGarvey, S.E. Eveloff, and P.D. Levinson, Body fat distribu-tion and sleep apnea severity in women. Chest, 1995;107(2):362–366.
Vgontzas, A.N., D.A. Papanicolaou, E.O. Bixler, et al., Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. J Clin Endocrinol Metab, 2000;85(3):1151–1158.
Dancey, D.R., P.J. Hanly, C. Soong, B. Lee, J. Shepard, and V. Hoffstein, Gender differences in sleep apnea: the role of neck circumference. Chest, 2003;123(5):1544–1550.
Carrera, M., F. Barbé, J. Sauleda, et al., Effects of obesity upon genioglossus structure and func-tion in obstructive sleep apnoea. Eur Respir J, 2004;23(3):425–429.
Hatipoglu, U. and I. Rubinstein, Inflammation and obstructive sleep apnea syndrome pathogen-esis: a working hypothesis. Respiration, 2003;70(6):665–671.
Vgontzas, A.N., D.A. Papanicolaou, E.O. Bixler, A. Kales, K. Tyson, and G.P. Chrousos, Eleva-tion of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity. J Clin Endocrinol Metab, 1997;82(5):1313–1316.
Vgontzas, A.N., E. Zoumakis, H.M. Lin, E.O. Bixler, G. Trakada, and G.P. Chrousos, Marked decrease in sleepiness in patients with sleep apnea by etanercept, a tumor necrosis factor-alpha antagonist. J Clin Endocrinol Metab, 2004;89(9):4409–4413.
Vgontzas, A.N., E.O. Bixler, and G.P. Chrousos, Metabolic disturbances in obesity versus sleep apnoea: the importance of visceral obesity and insulin resistance. JIntern Med, 2003;254(1):32–44.
Zhou, X.S., S. Shahabuddin, B.R. Zahn, M.A. Babcock, and M.S. Badr, Effect of gender on the development of hypocapnic apnea/hypopnea during NREM sleep. J Appl Physiol, 2000;89(1):192–199.
Zhou, X.S., J.A. Rowley, F. Demirovic, M.P. Diamond, and M.S. Badr, Effect of testosterone on the apneic threshold in women during NREM sleep. J Appl Physiol, 2003;94(1):101–107.
Luboshitzky, R., A. Aviv, A. Hefetz, et al., Decreased pituitary-gonadal secretion in men with obstructive sleep apnea. J Clin Endocrinol Metab, 2002;87(7):3394–3398.
McCowan, K.C. and A. Malhotra, The correlation between obstructive sleep apnea and low gona-dotropin secretion in men. Sleep Med, 2003;4(1):83–84.
Gopal, M., S. Duntley, M. Uhles, and H. Attarian, The role of obesity in the increased prevalence of obstructive sleep apnea syndrome in patients with polycystic ovarian syndrome. Sleep Med, 2002;3(5):401–404.
Fogel, R.B., A. Malhotra, G. Pillar, S.D. Pittman, A. Dunaif, and D.P. White, Increased preva-lence of obstructive sleep apnea syndrome in obese women with polycystic ovary syndrome. J Clin Endocrinol Metab, 2001;86(3):1175–1180.
Vgontzas, A.N., R.S. Legro, E.O. Bixler, A. Grayev, A. Kales, and G.P. Chrousos, Polycystic ovary syndrome is associated with obstructive sleep apnea and daytime sleepiness: role of insulin resistance. J Clin Endocrinol Metab, 2001;86(2):517–520.
Goldberg, R., Treatment of obstructive sleep apnea, other than with continuous positive airway pressure. Curr Opin Pulm Med, 2000;6(6):496–500.
Kajaste, S., P.E. Brander, T. Telakivi, M. Partinen, and P. Mustajoki, A cognitive-behavioral weight reduction program in the treatment of obstructive sleep apnea syndrome with or without initial nasal CPAP: a randomized study. Sleep Med, 2004;5(2):125–131.
Sampol, G., X. Muñoz, M.T. Sagalés, Long-term efficacy of dietary weight loss in sleep apnoea/ hypopnoea syndrome. Eur Respir J, 1998;12(5):1156–1159.
Bahammam, A. and M. Kryger, Decision making in obstructive sleep-disordered breathing. Put-ting it all together. Clin Chest Med, 1998;19(1):87–97.
Chin, K., K. Shimizu, T. Nakamura, et al., Changes in intra-abdominal visceral fat and serum leptin levels in patients with obstructive sleep apnea syndrome following nasal continuous posi-tive airway pressure therapy. Circulation, 1999;100(7):706–712.
Brooks, B., P.A. Cistulli, M. Borkman, et al., Obstructive sleep apnea in obese noninsulin-depen-dent diabetic patients: effect of continuous positive airway pressure treatment on insulin respon-siveness. J Clin Endocrinol Metab, 1994;79(6):1681–1685.
Smurra, M., P. Philip, J. Taillard, C. Guilleminault, B. Bioulac, and H. Gin, CPAP treatment does not affect glucose-insulin metabolism in sleep apneic patients. Sleep Med, 2001;2(3):207–213.
Grunstein, R.R., D.J. Handelsman, S.J. Lawrence, C. Blackwell, I.D. Caterson, and C.E. Sullivan, Neuroendocrine dysfunction in sleep apnea: reversal by continuous positive airways pressure therapy. J Clin Endocrinol Metab, 1989;68(2):352–358.
Polo-Kantola, P., E. Rauhala, H. Helenius, R. Erkkola, K. Irjala, and O. Polo, Breathing during sleep in menopause: a randomized, controlled, crossover trial with estrogen therapy. Obstet Gynecol, 2003;102(1):68–75.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Humana Press Inc., Totowa, NJ
About this chapter
Cite this chapter
Aubuchon, M. (2006). Polycystic Ovary Syndrome and Obstructive Sleep Apnea. In: Attarian, H.P. (eds) Sleep Disorders in Women. Current Clinical Neurology. Humana Press. https://doi.org/10.1007/978-1-59745-115-4_11
Download citation
DOI: https://doi.org/10.1007/978-1-59745-115-4_11
Publisher Name: Humana Press
Print ISBN: 978-1-58829-592-7
Online ISBN: 978-1-59745-115-4
eBook Packages: MedicineMedicine (R0)